Authors
Latest:
Case 2 Presentation: 58-Year-Old Woman With GPPErin Boh, MD, emphasizes the importance of patient empowerment and physician education surrounding the management of GPP.
Latest:
Late-Breaking Data: Lutikizumab Shows Positive Results in Difficult-to-Treat HS After Failed TNF TherapyAlexandra Kimball, MD, FAAD, reviews late-breaking data at AAD on lutikizumab for hidradenitis suppurativa.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
2021’s Top Challenges Facing PhysiciansIn late 2020, our sister publication, Medical Economics®, conducted a Physicians Report asking physician audiences what they thought would be the most challenging issues they will face this year. Here is what the respondents said.
Latest:
Managing Plaque Psoriasis: Expert AdviceTakeaways from a panel discussion on newer biologic therapies to treat plaque psoriasis, and parting advice to other professionals who work in dermatology regarding best practices when using these drugs in their clinics.
Latest:
Understanding and Treating Pseudo Acne FulminansShanna Miranti, MMS, PA-C, reviews 2 patient cases of pseudo acne fulminans, offering perspectives on treatment and management strategies.
Latest:
The Beauty-From-Within Market Continues to GrowThe dietary supplement industry seeks to help consumers age gracefully.
Latest:
Considerations to Best Serve Transgender Patients Seeking Aesthetic CareRonda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Latest:
Top Meeting Takeaways From the Fall Clinical ConferenceClinicians fresh from the Fall Clinical Dermatology Conference discuss their top meeting takeaways and share some recommendations.
Latest:
Psoriasis and Sunburn: New Study Highlights Increased Risk and Clinical ImplicationsSara Osborne, a fourth-year medical student and the lead author on the study, spoke with Dermatology Times on key findings and explain the need for further investigation.
Latest:
Advances in HS: Insights and Interventions Shared at Annual ConferenceJennifer Hsiao, MD, shares insights on emerging therapies and comprehensive care strategies at the 2024 SDPA Annual Summer Dermatology Conference.
Latest:
Marcelo Bigal, MD, PhD: VENT-03's Modality Offers Hope for Targeted Therapy in Skin DisordersMarcelo Bigal, MD, PhD, discusses VENT-03's potential as a small molecule therapeutic in dermatology, among other fields.
Latest:
How to Effectively Partner with Patients to Optimize CareCombined, these efforts encourage active participation in the care process and drive sustained behavior change.
Latest:
AAD and VStrong Vitiligo Support Community Receive Inaugural Incyte Ingenuity Awards in VitiligoIncyte representative Todd Edwards discusses how the awards help address challenges faced by patients with vitiligo.
Latest:
Disseminated Erythema Migrans as a Result of Lyme DiseaseA 17-year-old male patient presents with multiple lesions developed on his trunk, face, and extremities that had previously been solitary, red expanding lesion on his right arm at the site of a tick bite that occurred during a hike.
Latest:
Lisa Swanson, MD, FAAD: The Current Topical Landscape for Pediatric PatientsSwanson discusses her SPD 2024 non-CME talk, expanding topical options for young patients, and more.
Latest:
The Mainstream Patient: January 3, 2023This week's edition of the Mainstream Patient features stories about dry shampoos that don't contain benzene, the best ferulic acid serums, Hijabi hair care, and more.
Latest:
Customization Drives Pediatric Acne Treatment RegimensTreatment regimens for pediatric acne should consider skin type, ethnicity, disease severity and personal preferences, according to one expert.
Latest:
Addressing Causes of Female Hair Loss and Exploring Preventative MeasuresThis expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.
Latest:
Richard Gallo, MD, PhD: Updates on Understanding the Pathophysiology of AcneGallo presented pearls on the pathophysiology of acne and how newer studies have changed acne treatment methodologies at AAD 2024.
Latest:
Proper Coding Gets Practices What They Are OwedA physician’s goal is to care for patients, but a key part of being able to provide that care is the eternal quest for payment. One way to ensure that a practice maximizes its coding regimen is to make sure each session can be efficiently billed.
Latest:
Differences in Anti-PD-1/CTLA-4 and Anti-PD-1/LAG-3 Reported in Recent StudyThe study examined the mechanisms of action associated with immune checkpoint inhibitor combination therapies.
Latest:
Tunlametinib Wins Approval in China for NRAS+ Advanced Melanoma After PD-1/PD-L1 TherapyChina’s NMPA has approved tunlametinib for the treatment of patients with NRAS-mutated advanced melanoma after prior anti–PD-1/PD-L1 therapy.
Latest:
Innovative Melanoma Treatment Among NCInnovation's $5.2 Million Research Funding RecipientsMichelle Bolas and Rukiyah T. Van Dross-Anderson, PhD, discuss the significance of NCInnovations’ funding and the clinical impact of Van Dross-Anderson's research in patients with advanced melanoma.
Latest:
Tapinarof Spotlight: Non-Steroidal Topical for Extended Relief in Plaque PsoriasisAn expert dermatologist examines the efficacy and potential of tapinarof cream, a novel non-steroidal topical treatment, in providing long-term relief for patients with plaque psoriasis.
Latest:
Improving Representation of Skin of Color in DermatologyMiranda Uzoma Ewelukwa, MD, FAAD, reviews how skin of color representation has evolved in dermatology, however, more advocacy is still needed.
Latest:
The Adalimumab Biosimiliar Pipeline: What's AheadFDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
